ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,082.19
      0.67%
      US Tech 100
      17,116.40
      0.82%
      Dow Jones
      38,142.92
      0.15%
      Brent Oil
      88.445
      0.33%
      Bitcoin
      63,928.08
      -0.86%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Reata Pharmaceuticals Inc (RETA)

      7. Reata Pharmaceuticals Inc (RETA) News

      RETA Reata Pharmaceuticals Inc

      172.36
      0.00 (0.00%)
      Pre Market
      Last Updated: 20:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 172.36 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      172.36
      more quote information »

      Recent News

      Date Time Source Heading
      4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      10/06/202316:07EDGAR2Form 15-12G - Securities registration termination [Section..
      9/28/202316:30EDGAR2Form SC 13D/A - General statement of acquisition of..
      9/26/202319:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202317:25EDGAR2Form 8-K - Current report
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/26/202316:25EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
      9/26/202316:23EDGAR2Form S-8 POS - Securities to be offered to employees in..
      9/26/202308:59GLOBEBiogen Completes Acquisition of Reata Pharmaceuticals
      9/21/202316:05EDGAR2Form 8-K - Current report
      9/21/202310:08BWReata Pharmaceuticals Stockholders Approve Merger..
      9/18/202317:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:26EDGAR2Form 144 - Report of proposed sale of securities
      9/12/202313:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      9/12/202313:16EDGAR2Form 8-K - Current report
      9/07/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/05/202316:09EDGAR2Form 144 - Report of proposed sale of securities
      9/05/202316:08EDGAR2Form 144 - Report of proposed sale of securities
      8/22/202308:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
      8/17/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/17/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/17/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/17/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/16/202317:04EDGAR2Form 144 - Report of proposed sale of securities
      8/16/202317:03EDGAR2Form 144 - Report of proposed sale of securities
      8/16/202316:55EDGAR2Form 144 - Report of proposed sale of securities
      8/16/202316:54EDGAR2Form 144 - Report of proposed sale of securities
      8/16/202316:53EDGAR2Form 144 - Report of proposed sale of securities
      8/15/202319:38EDGAR2Form 144 - Report of proposed sale of securities
      8/15/202319:32EDGAR2Form 144 - Report of proposed sale of securities
      8/15/202319:12EDGAR2Form 144 - Report of proposed sale of securities
      8/11/202316:38EDGAR2Form PREM14A - Preliminary proxy statements relating to..
      8/01/202317:17EDGAR2Form SC 13D/A - General statement of acquisition of..
      8/01/202316:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/01/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/01/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/01/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/31/202307:20IHMARKETNEWSMonday’s Wall Street Highlights: Palantir Technologies,..
      7/31/202307:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      7/31/202307:01EDGAR2Form 8-K - Current report

      Your Recent History

      NASDAQ
      RETA
      Reata Pharmaceuticals
      Delayed Upgrade Clock